Chemotherapy-induced Nausea And Vomiting (CINV)

Radiotherapy-Induced Nausea, Vomiting Affect QOL for Patients, Caregivers Differently

Radiotherapy-Induced Nausea, Vomiting Affect QOL for Patients, Caregivers Differently

By

Outcomes assessment of patients participating in several different trials quantified the effect of nausea and vomiting separately, and on both the patient and the caregiver.

Moderately Emetogenic Chemotherapy Drug Demonstrates High Emetogenic Potential

Moderately Emetogenic Chemotherapy Drug Demonstrates High Emetogenic Potential

By

Based on results of a prospective and retrospective study evaluating emetogenic potential of 50 chemotherapeutic regimens, researchers suggest changing the classification of irinotecan.

Olanzapine Use to Prevent Chemotherapy-Induced Nausea and Vomiting

Olanzapine Use to Prevent Chemotherapy-Induced Nausea and Vomiting

By

Why is the antipsychotic olanzapine (Zyprexa) being used to prevent nausea?

Palonosetron Noninferior to Ondansetron for Pediatric Chemotherapy-induced Vomiting

Palonosetron Noninferior to Ondansetron for Pediatric Chemotherapy-induced Vomiting

By

In a prospective study, researchers sought to determine the noninferiority of palonosetron to ondansetron in pediatric patients with cancer receiving moderate or high emetogenic chemotherapy.

Palonosetron Prevents Delayed Nausea and Vomiting After CHOP in Non-Hodgkin Lymphoma

Palonosetron Prevents Delayed Nausea and Vomiting After CHOP in Non-Hodgkin Lymphoma

By

Palonosetron effectively prevents and manages delayed CINV in patients with non-Hodgkin lymphoma.

ASCO Updates Guidelines for Antiemetic Therapy in Adult, Pediatric Patients Receiving Chemotherapy

ASCO Updates Guidelines for Antiemetic Therapy in Adult, Pediatric Patients Receiving Chemotherapy

By

The American Society of Clinical Oncology (ASCO) convened a panel of experts to update its clinical guidelines for antiemetic therapy in patients receiving chemotherapy. A notable change is the addition of olanzapine in emetic regimens for adult patients.

Rolapitant Eases CINV in Patients Receiving Highly, Moderately Emetogenic Chemotherapy

Rolapitant Eases CINV in Patients Receiving Highly, Moderately Emetogenic Chemotherapy

By

Long-acting NK-1 receptor antagonist rolapitant demonstrates significant efficacy in managing CINV in patients receiving HEC or MEC for cancer.

Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy

Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy

By

Supplemental ginger before and during treatment raises antioxidant levels in patients undergoing chemotherapy.

Olanzapine Efficacious for Treatment of Breakthrough CINV

Olanzapine Efficacious for Treatment of Breakthrough CINV

By

This study compared the effectiveness of olazapine, palonosetron, and ondansetron in the treatment of CINV in patients receiving HSCT who are refractory to prophylactic antiemetic agents.

Overuse of Antiemetics Prevalent Among Patients Receiving Low Emetogenic Chemo

Overuse of Antiemetics Prevalent Among Patients Receiving Low Emetogenic Chemo

By

Antiemetic overuse is prevalent among patients with cancer receiving emetogenic chemotherapy and leads to unnecessary spending.

Rolapitant Improves CINV Prevention in Patients With GI Cancers

Rolapitant Improves CINV Prevention in Patients With GI Cancers

By

Adding rolapitant to a 5-HT3 receptor antagonist and dexamethasone significantly improved the prevention of CINV in patients with GI and CRC cancers receiving highly or moderately emetogenic chemotherapy.

MASCC Updates Guidelines for CINV Prevention in Children

By

The Multinational Association of Supportive Care in Cancer and the European Society for Medical Oncology updated their 2009 consensus recommendations for the prevention of acute CINV in pediatric patients with cancer.

Using Olanzapine as an Antiemetic for Patients Undergoing Moderate or High-Emetic Risk Chemotherapy

Using Olanzapine as an Antiemetic for Patients Undergoing Moderate or High-Emetic Risk Chemotherapy

By

Some of our patients receive olanzapine (Zyprexa) as an antiemetic. Is this a typical use of this drug?

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs